GPR119 receptor agonists
US8188098B2 · kind B2 · utility
5Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2009 |
| Grant date | May 29, 2012 |
| Priority date | — |
| Expiry date | Dec 2, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.